Patent Applications for estrogens, esterified

US Patent Applications for estrogens, esterified

US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
	6,399,331	METHOD FOR CULTURING RECOMBINANT CELLS	2000-11-30	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2010-07-05
	7,147,867	DOSAGE FORM COMPRISING LIQUID FORMULATION	2000-12-19	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2015-01-12
		USE OF ESTROGEN TO MODIFY THE AMOUNT OF SEROTONIN TRANSPORTER OR ITS MRNA	1998-11-25	Abandoned -- Failure to Respond to an Office Action	2001-10-09
	6,297,290	COMPOSITION CONTAINING A NERVE FIBRE REACTIVITY MODULATING COMPOUND	1998-09-04	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2009-11-02
	6,977,251	5-ANDROSTENE-3B,17XDIOL AS AN INHIBITOR OF TUMOR GROWTH	1999-01-06	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2010-01-18
		Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol	2001-04-11	Abandoned -- Failure to Respond to an Office Action	2002-05-15
	6,458,385	HYDROGELS CONTAINING ABSORBABLE POLYOXAAMIDES	2001-04-10	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2014-10-27

WIPO Patent Applications for estrogens, esterified

WIPO Patent Application	Title	Patent Filing Date

Japanese Patent Applications for estrogens, esterified

JP Patent Application	Title	Patent Filing Date